AccuStem Sciences Changes Auditors to Marcum LLP
Ticker: ACUT · Form: 8-K · Filed: Dec 30, 2024 · CIK: 1850767
| Field | Detail |
|---|---|
| Company | Accustem Sciences Inc. (ACUT) |
| Form Type | 8-K |
| Filed Date | Dec 30, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
TL;DR
AccuStem swapped auditors from BDO USA to Marcum LLP, effective June 17, 2024.
AI Summary
AccuStem Sciences Inc. announced on June 17, 2024, a change in its certifying accountant. The company has appointed Marcum LLP as its new independent registered public accounting firm, effective immediately. This change follows the resignation of the previous auditor, BDO USA, P.A.
Why It Matters
A change in auditors can signal potential concerns about past financial reporting or a desire for a fresh perspective on financial controls.
Risk Assessment
Risk Level: medium — Changes in auditors can sometimes precede or coincide with financial restatements or other accounting issues.
Key Players & Entities
- AccuStem Sciences Inc. (company) — Registrant
- Marcum LLP (company) — New Certifying Accountant
- BDO USA, P.A. (company) — Former Certifying Accountant
- June 17, 2024 (date) — Effective Date of Change
FAQ
When was the change in certifying accountant effective?
The change in certifying accountant was effective as of June 17, 2024.
Who is the new certifying accountant for AccuStem Sciences Inc.?
The new certifying accountant for AccuStem Sciences Inc. is Marcum LLP.
Who was the previous certifying accountant?
The previous certifying accountant for AccuStem Sciences Inc. was BDO USA, P.A.
What is the company's principal executive office address?
The company's principal executive office is located at 5 Penn Plaza, 19th Floor, #1954, New York, NY 10001.
What is the company's state of incorporation?
The company is incorporated in Delaware.
Filing Stats: 522 words · 2 min read · ~2 pages · Grade level 13.9 · Accepted 2024-12-30 17:13:59
Filing Documents
- form8-k.htm (8-K) — 36KB
- 0001493152-24-052550.txt ( ) — 205KB
- acut-20240617.xsd (EX-101.SCH) — 3KB
- acut-20240617_lab.xml (EX-101.LAB) — 33KB
- acut-20240617_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ACCUSTEM SCIENCES INC. Date: December 30, 2024 By: /s/ Wendy Blosser Wendy Blosser Chief Executive Officer -3-